3 April 2024 - Today, the US FDA approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with ...
2 April 2024 - RemeGen has obtained fast track designation by the US FDA recently for its innovative BLyS/APRIL dual-target ...
3 April 2024 - The agenda for the July 2024 PBAC meeting is now available. ...
2 April 2024 - Zymeworks is pleased to announce, along with our partners Jazz Pharmaceuticals, completion of the rolling submission of ...
3 April 2024 - NICE has published final evidence-based recommendations on the use of dostarlimab (Jemperli) in combination with platinum-based ...
2 April 2024 - Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled ...
2 April 2024 - Fast track designation for NOX-A12 follows recently announced FDA clearance of investigational new drug application for Phase ...
2 April 2024 - Roche designed its trial for both approval and health technology assessments but the analyses planned for ...
2 April 2024 - What the Inflation Reduction Act means for the cost of health care. ...
2 April 2024 - Positive HTA recommendation for reimbursement signifies an important milestone towards public funding to treat eligible patients with ...
2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive ...
2 April 2024 - Application based on results from the TROPION-Breast01 Phase 3 trial. ...
28 March 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
1 April 2024 - Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate to severe plaque psoriasis in adults, ...
28 March 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...